# PKC as Serum Biomarkers for Depression

> **NCT04531423** · NA · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 100 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SSRI + golimumab
- **OTHER:** SSRI + placebo

## Key facts

- **NCT ID:** NCT04531423
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531423, "PKC as Serum Biomarkers for Depression". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04531423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*